Jan Skvarka

Jan Skvarka is the CEO of Tal Medical, a clinical stage neuroscience company developing a non-invasive, rapid-acting neuromodulation therapy for depression. Prior to Tal, Jan was a leading partner in the Healthcare Practice of Bain and Company, Boston, and previously an M&A advisor with Price Waterhouse in Vienna and London. Jan holds an MBA from Harvard Business School. He is based in Boston.